Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kauffman Michael
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   800,347    

Indirect Shares

   898,131      
Direct Value   $971,028    

Indirect Value

   $1,032,851      
Total Shares   1,698,478      
Total Value   $2,003,879      


Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $820,821 Verastem, Inc. $92,000 Kezar Life Sciences, Inc. $48,767 Adicet Bio, Inc $9,440 Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $820,821 Verastem, Inc. $92,000 Kezar Life Sciences, Inc. $48,767 Adicet Bio, Inc $9,440
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    12    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    12    
   
     Gain/Loss Ratio :
   0.0   
   -12.0   
     Percentage Gain/Loss :
     0.0%
 -553.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX Chief Medical Officer 2010-02-09 9,000 2009-11-16 0    Premium*  
            Karyopharm Therapeutics Inc. KPTI Director 2022-02-28 713,757 2022-02-28 898,131    Premium*  
            Verastem, Inc. VSTM Director 2018-09-28 8,000 2014-09-17 0    Premium*  
            Kezar Life Sciences, Inc. KZR Director 2022-01-03 63,690 2018-06-25 0    Premium*  
            Adicet Bio, Inc ACET Director 2023-06-01 5,900 2023-06-01 0    Premium*  
* Premium Members only  

Records found :    156         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-04-09 4 OE $4.75 $47,520 D/D 10,000 565,122 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-04-09 4 AS $20.64 $206,404 D/D (10,000) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-07 4 OE $4.75 $35,640 D/D 7,500 562,622 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-07 4 OE $4.75 $35,640 I/I 7,500 763,989 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-07 4 AS $19.63 $147,209 D/D (7,500) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-07 4 AS $19.63 $147,205 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-15 4 AS $18.65 $139,841 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-15 4 OE $0.03 $248 I/I 7,500 763,989 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-18 4 AS $20.00 $150,000 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-05-18 4 OE $0.03 $248 I/I 7,500 763,989 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-09 4 AS $18.50 $138,746 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-09 4 OE $4.75 $35,640 I/I 7,500 763,989 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-10 4 AS $18.13 $135,944 D/D (7,500) 555,122 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-10 4 OE $4.75 $35,640 D/D 7,500 562,622 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-15 4 AS $16.20 $122,779 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-15 4 OE $0.03 $248 I/I 7,500 756,846 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-22 4 AS $20.00 $150,000 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-06-22 4 OE $0.03 $248 I/I 7,500 763,989 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-07-15 4 AS $19.43 $145,723 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-07-15 4 OE $0.03 $248 I/I 7,500 763,989 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-08-17 4 OE $0.03 $49 I/I 1,477 757,966 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-08-17 4 AS $15.00 $22,155 I/I (1,477) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-10-12 4 OE $0.03 $248 I/I 7,500 763,989 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-10-12 4 AS $14.89 $111,683 I/I (7,500) 756,489 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2021-02-05 4 OE $0.00 $0 I/I 14,300 770,789 0 -
  156  Records found
  1   2   3   4   5  6   7      
  Page 5 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us